Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in infants and young children. There are no licensed RSV vaccines available, and the few treatment options for high-risk individuals are either extremely costly or cause severe side effects and toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Elisa C., Garg, Ravendra, Shrivastava, Pratima, Gomis, Susantha, van Drunen Littel-van den Hurk, Sylvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126411/
https://www.ncbi.nlm.nih.gov/pubmed/27771388
http://dx.doi.org/10.1016/j.antiviral.2016.10.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126411/
https://www.ncbi.nlm.nih.gov/pubmed/27771388
http://dx.doi.org/10.1016/j.antiviral.2016.10.008

Ejemplares similares